Designing PEGylated therapeutic molecules: advantages in ADMET properties.
about
Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.Product development issues for PEGylated proteins.PEGylation and its impact on the design of new protein-based medicines.Overview on biotherapeutic proteins: impact on bioanalysis.Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties.In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.
P2860
Designing PEGylated therapeutic molecules: advantages in ADMET properties.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Designing PEGylated therapeutic molecules: advantages in ADMET properties.
@en
type
label
Designing PEGylated therapeutic molecules: advantages in ADMET properties.
@en
prefLabel
Designing PEGylated therapeutic molecules: advantages in ADMET properties.
@en
P2860
P1476
Designing PEGylated therapeutic molecules: advantages in ADMET properties.
@en
P2093
Amir Azadi
Pedram Rafiei
P2860
P304
P356
10.1517/17460441.3.11.1293
P407
P577
2008-11-01T00:00:00Z